S2 E8: Novo Nordisk Breakthrough Weigh-Lost Drug, Q3 Market Performance & African Startups Collapse

Paglalarawan

In Episode 8 of season 2, Novo Nordisk Breakthrough WeightLoss Drug, Q3 Market Performance etc w/James Okpare & Sam Adekunle In this episode, the podcast centers on Wegovy, a breakthrough weight loss drug from Novo Nordisk tackling obesity. In addition, it reviews the US Federal Reserve's report on the Q3 stock market performance. Lastly, Sam and James dive into the recent collapse of African startups influenced by financial management, regulatory challenges, and funding constraints.